Klow vs Thymosin Beta-4 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Klow is a vendor peptide blend combining TB-500, BPC-157, KPV, and GHK-Cu - four compounds covering systemic tissue repair, angiogenesis, gut protection, anti-inflammation, and skin regeneration. It is the expanded version of Tri-Heal (TB-500 + BPC-157 + KPV), with GHK-Cu added f...
Calculate Klow dose →Thymosin Beta-4 (TB-4) is the full-length 43-amino acid actin-sequestering peptide from which the commonly used research fragment TB-500 (residues 17-23, LKKTETQ) is derived. TB-4 is the most abundant thymosin-family protein in virtually all mammalian cells, where it maintains th...
Calculate Thymosin Beta-4 dose →| Parameter | Klow | Thymosin Beta-4 |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Vendor Blend | Extensively Studied |
| Half-Life | - | ~30-60 min (plasma) |
| Typical Dose | - | 1.5-2.5 mg, 2-3x/week |
| Frequency | - | 2-3 times per week |
| Route | Subcutaneous | Subcutaneous, IV, Topical, Intranasal |
| FDA Status | Not Approved | Phase II |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.